GT BIOPHARMA, INC. Stock Issued During Period, Shares, Other
GT BIOPHARMA, INC. (GTBP) had Stock Issued During Period, Shares, Other of 24.02 thousand shares as of 2025-05-12, per its 10-K filed 2026-03-02.
Financial Statements › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesOther · last filed 2026-03-02
- 2025-05-12: Stock Issued During Period, Shares, Other 24.02K shares.
- 2021-06-30: Stock Issued During Period, Shares, Other 6 month 25.00K shares.
| Period end | Stock Issued During Period, Shares, Other | Stock Issued During Period, Shares, Other 6 month |
|---|---|---|
| 2025-05-12 | 24.02K shares 10-K · filed 2026-03-02 | |
| 2021-06-30 | 25.00K shares 10-Q/A · filed 2021-12-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |